Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa
Journal of Burn Care & Research · 2023
DOI: 10.1093/jbcr/irac189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2023. Verfasst von Kathleen S Romanowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Acute Care Surgery Division, Department of Surgery, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Burns. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences, National Institutes of Health.
Abstract (Originalsprache)
Hidradenitis suppurativa (HS), a chronic disease of the apocrine bearing skin causing induration, pain, draining sinuses, and subcutaneous abscesses, significantly impairs patients’ quality of life (QOL). Full-thickness excision followed by skin grafting of the involved area can be curative. Herein, we evaluated the impact of this surgical treatment on QOL and depression symptomatology. Adult patients (≥18 years) who consented to participate filled out the dermatology quality of life (DLQI) and the Patient History Questionnaire (PHQ-9) at consent and at 1, 6, and 12 months post-initial evaluation and surgery. Demographics, HS, admission, and operative information were collected. Sixteen patients were included. Subjects were mainly white (81.3 %) and female (56.3%) with a median age of 38.2 (Interquartile range: 34.2–54.5); 62.5% were obese (BMI= 39.7 [28.4–50.6]). Half of the subjects presented with HS in 2 or more areas. Six patients were still undergoing surgeries at 6 months. One-, six-, and 12-month follow-up surveys were obtained from 14, 11, and 8 subjects for DQLI and from 14, 9, and 5 subjects for PHQ9. DLQI scores significantly decreased at 6 months compared to baseline, which indicates QOL improvement (10 [4–20] vs 15.5 [12–21.8], P = .036). Although not significant, PHQ9 scores tended to decrease. For those with the worst disease, DLQI significantly decreased at both 6 (P = .049) and 12 months (P = .047) compared to baseline. Despite a small sample size, our data suggest that aggressive surgical treatment improves the QOL of HS patients. Further studies are warranted to confirm our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Acute Care Surgery Division, Department of Surgery, University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Colette Galet
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Romanowski, K. S., Galet, C., Torres, M., & Wibbenmeyer, L. (2023). Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irac189
Vancouver
Romanowski KS, Galet C, Torres M, Wibbenmeyer L. Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa. Journal of Burn Care & Research. 2023. doi:10.1093/jbcr/irac189
BibTeX
@article{Romanowski2023,
author = {Romanowski, Kathleen S and Galet, Colette and Torres, Marlon and Wibbenmeyer, Lucy},
title = {Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa},
journal = {Journal of Burn Care & Research},
year = {2023},
doi = {10.1093/jbcr/irac189}
}
EUVIMED